Logo image of ZBRA

ZEBRA TECHNOLOGIES CORP-CL A (ZBRA) Stock Fundamental Analysis

USA - NASDAQ:ZBRA - US9892071054 - Common Stock

317.32 USD
-1.09 (-0.34%)
Last: 9/17/2025, 8:14:00 PM
317.32 USD
0 (0%)
After Hours: 9/17/2025, 8:14:00 PM
Fundamental Rating

6

We assign a fundamental rating of 6 out of 10 to ZBRA. ZBRA was compared to 125 industry peers in the Electronic Equipment, Instruments & Components industry. ZBRA scores excellent on profitability, but there are some minor concerns on its financial health. ZBRA has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

In the past year ZBRA was profitable.
ZBRA had a positive operating cash flow in the past year.
In the past 5 years ZBRA has always been profitable.
Of the past 5 years ZBRA 4 years had a positive operating cash flow.
ZBRA Yearly Net Income VS EBIT VS OCF VS FCFZBRA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M 1B

1.2 Ratios

ZBRA's Return On Assets of 6.90% is amongst the best of the industry. ZBRA outperforms 85.60% of its industry peers.
ZBRA has a Return On Equity of 15.15%. This is amongst the best in the industry. ZBRA outperforms 84.80% of its industry peers.
The Return On Invested Capital of ZBRA (10.95%) is better than 85.60% of its industry peers.
ZBRA had an Average Return On Invested Capital over the past 3 years of 11.59%. This is above the industry average of 9.48%.
Industry RankSector Rank
ROA 6.9%
ROE 15.15%
ROIC 10.95%
ROA(3y)5.61%
ROA(5y)7.93%
ROE(3y)13.8%
ROE(5y)18.59%
ROIC(3y)11.59%
ROIC(5y)14.22%
ZBRA Yearly ROA, ROE, ROICZBRA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 30

1.3 Margins

With an excellent Profit Margin value of 10.56%, ZBRA belongs to the best of the industry, outperforming 86.40% of the companies in the same industry.
ZBRA's Profit Margin has declined in the last couple of years.
ZBRA's Operating Margin of 15.59% is amongst the best of the industry. ZBRA outperforms 88.80% of its industry peers.
In the last couple of years the Operating Margin of ZBRA has remained more or less at the same level.
The Gross Margin of ZBRA (48.59%) is better than 84.00% of its industry peers.
In the last couple of years the Gross Margin of ZBRA has remained more or less at the same level.
Industry RankSector Rank
OM 15.59%
PM (TTM) 10.56%
GM 48.59%
OM growth 3Y-5.09%
OM growth 5Y-0.99%
PM growth 3Y-10.68%
PM growth 5Y-2.66%
GM growth 3Y1.23%
GM growth 5Y0.68%
ZBRA Yearly Profit, Operating, Gross MarginsZBRA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30 40

5

2. Health

2.1 Basic Checks

ZBRA has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
Compared to 1 year ago, ZBRA has more shares outstanding
The number of shares outstanding for ZBRA has been reduced compared to 5 years ago.
The debt/assets ratio for ZBRA has been reduced compared to a year ago.
ZBRA Yearly Shares OutstandingZBRA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
ZBRA Yearly Total Debt VS Total AssetsZBRA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

ZBRA has an Altman-Z score of 4.25. This indicates that ZBRA is financially healthy and has little risk of bankruptcy at the moment.
ZBRA has a Altman-Z score of 4.25. This is in the better half of the industry: ZBRA outperforms 62.40% of its industry peers.
The Debt to FCF ratio of ZBRA is 2.55, which is a good value as it means it would take ZBRA, 2.55 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 2.55, ZBRA is in the better half of the industry, outperforming 74.40% of the companies in the same industry.
A Debt/Equity ratio of 0.59 indicates that ZBRA is somewhat dependend on debt financing.
ZBRA has a Debt to Equity ratio of 0.59. This is in the lower half of the industry: ZBRA underperforms 75.20% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.59
Debt/FCF 2.55
Altman-Z 4.25
ROIC/WACC1.22
WACC8.97%
ZBRA Yearly LT Debt VS Equity VS FCFZBRA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B

2.3 Liquidity

A Current Ratio of 1.46 indicates that ZBRA should not have too much problems paying its short term obligations.
The Current ratio of ZBRA (1.46) is worse than 76.00% of its industry peers.
A Quick Ratio of 1.03 indicates that ZBRA should not have too much problems paying its short term obligations.
The Quick ratio of ZBRA (1.03) is worse than 76.00% of its industry peers.
Industry RankSector Rank
Current Ratio 1.46
Quick Ratio 1.03
ZBRA Yearly Current Assets VS Current LiabilitesZBRA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

6

3. Growth

3.1 Past

ZBRA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 75.81%, which is quite impressive.
Measured over the past 5 years, ZBRA shows a small growth in Earnings Per Share. The EPS has been growing by 0.88% on average per year.
ZBRA shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 19.12%.
ZBRA shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 2.12% yearly.
EPS 1Y (TTM)75.81%
EPS 3Y-9.87%
EPS 5Y0.88%
EPS Q2Q%13.52%
Revenue 1Y (TTM)19.12%
Revenue growth 3Y-3.98%
Revenue growth 5Y2.12%
Sales Q2Q%6.24%

3.2 Future

ZBRA is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 14.88% yearly.
ZBRA is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 6.24% yearly.
EPS Next Y16.18%
EPS Next 2Y14.49%
EPS Next 3Y12.83%
EPS Next 5Y14.88%
Revenue Next Year6.69%
Revenue Next 2Y7.01%
Revenue Next 3Y6.27%
Revenue Next 5Y6.24%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
ZBRA Yearly Revenue VS EstimatesZBRA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2B 4B 6B 8B
ZBRA Yearly EPS VS EstimatesZBRA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 10 20 30

6

4. Valuation

4.1 Price/Earnings Ratio

ZBRA is valuated rather expensively with a Price/Earnings ratio of 20.99.
79.20% of the companies in the same industry are more expensive than ZBRA, based on the Price/Earnings ratio.
ZBRA's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 27.20.
The Price/Forward Earnings ratio is 17.92, which indicates a rather expensive current valuation of ZBRA.
Based on the Price/Forward Earnings ratio, ZBRA is valued a bit cheaper than the industry average as 75.20% of the companies are valued more expensively.
When comparing the Price/Forward Earnings ratio of ZBRA to the average of the S&P500 Index (22.70), we can say ZBRA is valued slightly cheaper.
Industry RankSector Rank
PE 20.99
Fwd PE 17.92
ZBRA Price Earnings VS Forward Price EarningsZBRA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, ZBRA is valued a bit cheaper than 66.40% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, ZBRA is valued cheaply inside the industry as 85.60% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 18.92
EV/EBITDA 17.85
ZBRA Per share dataZBRA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60 80 100

4.3 Compensation for Growth

ZBRA's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
The excellent profitability rating of ZBRA may justify a higher PE ratio.
ZBRA's earnings are expected to grow with 12.83% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.3
PEG (5Y)23.81
EPS Next 2Y14.49%
EPS Next 3Y12.83%

0

5. Dividend

5.1 Amount

ZBRA does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

ZEBRA TECHNOLOGIES CORP-CL A

NASDAQ:ZBRA (9/17/2025, 8:14:00 PM)

After market: 317.32 0 (0%)

317.32

-1.09 (-0.34%)

Chartmill FA Rating
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)08-05 2025-08-05/bmo
Earnings (Next)10-28 2025-10-28/bmo
Inst Owners92.77%
Inst Owner Change2.5%
Ins Owners0.7%
Ins Owner Change0.03%
Market Cap16.14B
Analysts78.33
Price Target369.68 (16.5%)
Short Float %2.04%
Short Ratio1.93
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)7.72%
Min EPS beat(2)6.47%
Max EPS beat(2)8.97%
EPS beat(4)3
Avg EPS beat(4)5.15%
Min EPS beat(4)-0.59%
Max EPS beat(4)8.97%
EPS beat(8)7
Avg EPS beat(8)6.45%
EPS beat(12)8
Avg EPS beat(12)3.24%
EPS beat(16)12
Avg EPS beat(16)3.69%
Revenue beat(2)0
Avg Revenue beat(2)-1.03%
Min Revenue beat(2)-1.45%
Max Revenue beat(2)-0.61%
Revenue beat(4)1
Avg Revenue beat(4)-0.4%
Min Revenue beat(4)-1.45%
Max Revenue beat(4)1.13%
Revenue beat(8)4
Avg Revenue beat(8)0%
Revenue beat(12)5
Avg Revenue beat(12)-1.49%
Revenue beat(16)7
Avg Revenue beat(16)-1.04%
PT rev (1m)3.92%
PT rev (3m)13.83%
EPS NQ rev (1m)1.51%
EPS NQ rev (3m)11.33%
EPS NY rev (1m)6.8%
EPS NY rev (3m)6.58%
Revenue NQ rev (1m)0.15%
Revenue NQ rev (3m)1.36%
Revenue NY rev (1m)0.69%
Revenue NY rev (3m)0.75%
Valuation
Industry RankSector Rank
PE 20.99
Fwd PE 17.92
P/S 3.11
P/FCF 18.92
P/OCF 17.44
P/B 4.46
P/tB N/A
EV/EBITDA 17.85
EPS(TTM)15.12
EY4.76%
EPS(NY)17.71
Fwd EY5.58%
FCF(TTM)16.77
FCFY5.29%
OCF(TTM)18.19
OCFY5.73%
SpS102.06
BVpS71.13
TBVpS-14.04
PEG (NY)1.3
PEG (5Y)23.81
Profitability
Industry RankSector Rank
ROA 6.9%
ROE 15.15%
ROCE 12.75%
ROIC 10.95%
ROICexc 12.7%
ROICexgc 60.9%
OM 15.59%
PM (TTM) 10.56%
GM 48.59%
FCFM 16.44%
ROA(3y)5.61%
ROA(5y)7.93%
ROE(3y)13.8%
ROE(5y)18.59%
ROIC(3y)11.59%
ROIC(5y)14.22%
ROICexc(3y)12.35%
ROICexc(5y)15.17%
ROICexgc(3y)83.03%
ROICexgc(5y)N/A
ROCE(3y)13.49%
ROCE(5y)16.56%
ROICexcg growth 3Y-36.88%
ROICexcg growth 5Y-17.49%
ROICexc growth 3Y-16.79%
ROICexc growth 5Y-8.38%
OM growth 3Y-5.09%
OM growth 5Y-0.99%
PM growth 3Y-10.68%
PM growth 5Y-2.66%
GM growth 3Y1.23%
GM growth 5Y0.68%
F-Score9
Asset Turnover0.65
Health
Industry RankSector Rank
Debt/Equity 0.59
Debt/FCF 2.55
Debt/EBITDA 2.17
Cap/Depr 42.11%
Cap/Sales 1.39%
Interest Coverage 250
Cash Conversion 94.39%
Profit Quality 155.66%
Current Ratio 1.46
Quick Ratio 1.03
Altman-Z 4.25
F-Score9
WACC8.97%
ROIC/WACC1.22
Cap/Depr(3y)40.17%
Cap/Depr(5y)39.59%
Cap/Sales(3y)1.46%
Cap/Sales(5y)1.39%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)75.81%
EPS 3Y-9.87%
EPS 5Y0.88%
EPS Q2Q%13.52%
EPS Next Y16.18%
EPS Next 2Y14.49%
EPS Next 3Y12.83%
EPS Next 5Y14.88%
Revenue 1Y (TTM)19.12%
Revenue growth 3Y-3.98%
Revenue growth 5Y2.12%
Sales Q2Q%6.24%
Revenue Next Year6.69%
Revenue Next 2Y7.01%
Revenue Next 3Y6.27%
Revenue Next 5Y6.24%
EBIT growth 1Y68.19%
EBIT growth 3Y-8.88%
EBIT growth 5Y1.11%
EBIT Next Year15.2%
EBIT Next 3Y11.42%
EBIT Next 5Y11.57%
FCF growth 1Y484.25%
FCF growth 3Y-1.88%
FCF growth 5Y8.86%
OCF growth 1Y312.95%
OCF growth 3Y-1.78%
OCF growth 5Y8.14%